Sanofi's BTK Progress, And Other News: The Good, Bad And Ugly Of Biopharma [Seeking Alpha]
IMMUNOMEDICS (IMMU)
Last immunomedics earnings: 2/27 04:00 pm
Check Earnings Report
US:NASDAQ Investor Relations:
immunomedics.com/2017/immunomedics-announces-presentations-investor-event-2017-san-antonio-breast-cancer-symposium
Company Research
Source: Seeking Alpha
SummarySanofi's BTK inhibitor shows promise in RRMS.Kiniksa announces positive data from a dermatology trial.Immunomedics receives approval for cancer drug.Sanofi Shows Promising Results for BTK Inhibitors in Relapsing Multiple SclerosisSanofi (NASDAQ:SNYworkingThe data showed that the BTK inhibitor significantly reduced disease activity associated with multiple sclerosis as measured using MRI. The Phase 2 study aimed to evaluate the dose-response relationship after 12 weeks of treatment with SAR442168. The measurement was done by determining the number of new brain lesions using MRI.John Reed, MD, PhD, Sanofi’s Global Head of Research & DevelopmentsaidThe trialstudiedThe Phase 2b trial was a randomized, placebo-controlled, double-blind, cross-over, dose-ranging trial spread over a period of 12 weeks. One group consisting of 64 subjects received one of the four doses of the drug candidate for the first 12 weeks and then were turned to placebo arm for four weeks. The second group of 66
Show less
Read more
Impact Snapshot
Event Time:
IMMU
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
IMMU alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
IMMU alerts
High impacting IMMUNOMEDICS news events
Weekly update
A roundup of the hottest topics